NexImmune Inc. (NEXI)
0.00
-0.14 (-100.00%)
At close: Mar 03, 2025, 9:30 AM
No 1D chart data available
| Bid | n/a |
| Market Cap | 139 |
| Revenue (ttm) | 2.14M |
| Net Income (ttm) | -20.83M |
| EPS (ttm) | -18.51 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.03 |
| Analyst | n/a |
| Ask | n/a |
| Volume | 300 |
| Avg. Volume (20D) | 7,098 |
| Open | 0.00 |
| Previous Close | 0.14 |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 9.40 |
| Beta | 1.92 |
About NEXI
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials f...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 12, 2021
Employees 6
Stock Exchange NASDAQ
Ticker Symbol NEXI
Website https://www.neximmune.com
